Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Insomnia in the Elderly
NCT00230737Phase 2Completed
- Start
- Oct 2004
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of melatonin in Insomnia (3 arms). Primary endpoint: Peak Melatonin Level at 42 days. Started Oct 2004; status: completed.
02
Drugs
melatonin
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00230737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00230737.